| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/13/2011 | EP2341919A1 Cgrp receptor antagonists |
| 07/13/2011 | EP2341907A1 Synergistic combinations of a macrocyclic inhibitor of hcv and a nucleoside |
| 07/13/2011 | EP2341898A2 Stable solid formulations of gc-c receptor agonist polypeptides suitable for oral administration |
| 07/13/2011 | EP2341897A2 Nanoparticles for immunotherapy |
| 07/13/2011 | EP2146750B1 Stabilized suspension |
| 07/13/2011 | EP2143438B1 Compositions and methods for the diagnosis and treatment of tumors |
| 07/13/2011 | EP1965831B1 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 07/13/2011 | EP1934245B1 Y2 selective receptor agonists for therapeutic interventions |
| 07/13/2011 | EP1812466B1 Compositions and methods for the control of mammary cell number |
| 07/13/2011 | EP1789068B1 Composition and use for prevention or treatment of stomatitis |
| 07/13/2011 | EP1718670B1 Il-15 binding site for il 15-ralpha and specific il-15 mutants having agonist/antagonist activity |
| 07/13/2011 | EP1718322B1 Synergistic compositions with fk-228 |
| 07/13/2011 | EP1660652B1 Amino acid-substituted coagulation factor v |
| 07/13/2011 | EP1654283B1 Improved method of purifying tfpi and tfpi analogs |
| 07/13/2011 | EP1649017B1 Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer |
| 07/13/2011 | EP1543158B1 Regulated aptamer therapeutics |
| 07/13/2011 | EP1465990B1 Truncated lysostaphin molecule with enhanced staphylolytic activity |
| 07/13/2011 | EP1442140B1 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 07/13/2011 | EP1289553B1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 07/13/2011 | EP1281323B1 Compositions containing peptide and electrolyte excretion promoter and foods containing the same |
| 07/13/2011 | EP1190043B1 Glycoprotein vi and uses thereof |
| 07/13/2011 | EP1178825B1 Adjuvant combination formulations |
| 07/13/2011 | EP1178796B1 Orazamide orotate for the prevention of liver damage |
| 07/13/2011 | EP0979080B1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/13/2011 | CN1922309B A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/13/2011 | CN1897922B Process for producing pellets for pharmaceutical compositions |
| 07/13/2011 | CN102124122A Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells |
| 07/13/2011 | CN102124101A The large form of human 2', 5'-oligoadenylate synthetase OAS3 for preventing or treating infection with positive-sense single-stranded RNA viruses |
| 07/13/2011 | CN102124026A Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 07/13/2011 | CN102123735A Agent for induction/maintenance of remission |
| 07/13/2011 | CN102123730A Heat-stable, aqueous lactoferrin composition and its preparation and use |
| 07/13/2011 | CN102123729A Use of hsp70 as a regulator of enzymatic activity |
| 07/13/2011 | CN102123728A Compounds for treating amyloidoses |
| 07/13/2011 | CN102123727A Compounds for treating beta-amyloidoses |
| 07/13/2011 | CN102123726A Compounds for treating symptoms associated with parkinson's disease |
| 07/13/2011 | CN102123725A Opiorphin for use as a psychostimulant agent |
| 07/13/2011 | CN102123724A Compositions and methods for treating influenza |
| 07/13/2011 | CN102123723A Glucagon/GLP-1 receptor co-agonists |
| 07/13/2011 | CN102123722A Improved peptide mediators of cholesterol efflux |
| 07/13/2011 | CN102123721A Therapeutic inhibitors of PAI-1 function and methods of their use |
| 07/13/2011 | CN102121020A Gene complete sequence of siganus oramin L-amino acid oxidase and application thereof |
| 07/13/2011 | CN102121014A Xenopus tropicalis interleukin 8 cDNA, cloning method and recombination application thereof |
| 07/13/2011 | CN102121011A B lymphocyte and proliferation-inducing ligand cDNA from danio rerio, cloning method and recombinant application thereof |
| 07/13/2011 | CN102121010A Takifugu obscures B lymphocyte stimulating factor cDNA and cloning method and recombination application thereof |
| 07/13/2011 | CN102120781A Preparation and application of novel oral insulin nanoparticles |
| 07/13/2011 | CN102120764A Angiogenesis of triple mutant low-oxygen inducible factor 1 alpha induced by auxiliary activating factors and application thereof |
| 07/13/2011 | CN102120760A Antibacterial peptide derived from phage and application thereof |
| 07/13/2011 | CN102120759A Polypeptide as well as derivatives and application thereof |
| 07/13/2011 | CN102120757A Hybrid peptide using 3S-tetrahydro-beta-carboline-3-carboxylic acid as connecting arm, and preparation method and application thereof |
| 07/13/2011 | CN102120037A Human epididymis secretion sperm bonding protein HEL-S-64C as well as coding gene and application thereof |
| 07/13/2011 | CN102120033A Collagen sustained-release carrier material for promoting repair of various traumas in oral and maxillofacial regions and method for preparing same |
| 07/13/2011 | CN102120032A Water-soluble substrate suitable for preparing water-soluble preparations of bleomycin and homologues thereof |
| 07/13/2011 | CN102120031A Pharmaceutical compositions and methods for accelerating wound healing |
| 07/13/2011 | CN102120027A Composition of ciclosporin A and amphipathic chitosan derivatives and preparation thereof |
| 07/13/2011 | CN102120026A 21(S) argatroban intravenous injection with alcohol as solubilizer |
| 07/13/2011 | CN102119928A Preparation method of lumbrokinase enteric-coated pellets |
| 07/13/2011 | CN102119922A 21(S) Argatroban intravenous injection taking acid as solubilizer |
| 07/13/2011 | CN102119917A Preparation method of recombinant human endostatin temperature sensitive gel |
| 07/13/2011 | CN101569749B preparation method of dextran-hemoglobin conjugate as potential blood substitute |
| 07/13/2011 | CN101518644B Application of Ang-2 and genes thereof in pharmacy |
| 07/13/2011 | CN101113169B Use of sorting protein SNX10 for suppressing growth of tumour cell |
| 07/13/2011 | CN101081232B Yak bone marrow glair polypeptides bone extract and the composition thereof and the preparing method |
| 07/13/2011 | CN101065482B Novel shuttle vector |
| 07/13/2011 | CN101044157B Compounds for proteasome enzyme inhibition |
| 07/12/2011 | US7977506 Amino acid for delivering active materials; bioavailability |
| 07/12/2011 | US7977469 biosynthesis of long chain polyunsaturated fatty acids like DHA (docosahexaenoic acid, 22:6, n-3); stress, diabetes, cancer, inflammatory disorders, and cardiovascular disorders |
| 07/12/2011 | US7977468 Chromosome 3p21.3 genes are tumor suppressors |
| 07/12/2011 | US7977465 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 07/12/2011 | US7977460 Compositions comprising coagulation factors IXA and VIII for the treatment of haemophilia A or B |
| 07/12/2011 | US7977456 Apparatus and method for separation of liquid phases of different density and for fluorous phase organic syntheses |
| 07/12/2011 | US7977455 Analogues of GLP-1 |
| 07/12/2011 | US7977317 Compositions and methods for modulating blood-brain barrier transport |
| 07/12/2011 | US7977316 Prevention and treatment of amyloidogenic diseases |
| 07/12/2011 | US7977315 prenylation enzyme inhibitors such as 5,9,13-trimethyl-2-nitrotetradeca-2,8,12-triene, used as anticarcinogenic or antitumor agents |
| 07/12/2011 | US7977313 Methods and compositions for promoting localization of pharmaceutically active agents to bone |
| 07/12/2011 | US7977312 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 07/12/2011 | US7977311 Methods and compositions for the prevention and treatment of anemia |
| 07/12/2011 | US7977310 Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes |
| 07/12/2011 | US7977309 Methods of using motilin homologs |
| 07/12/2011 | US7977308 Lys-Thr dipeptides and their use |
| 07/12/2011 | US7977307 Method for reducing pain with ziconotide and morphine |
| 07/12/2011 | US7977304 FK 228 derivates as HDAC inhibitors |
| 07/12/2011 | US7977091 Eukaryotic layered vector initiation systems |
| 07/12/2011 | US7977071 Binding moieties based on shark ignar domains |
| 07/12/2011 | US7977066 Method for preparing tryptophan rich peptides |
| 07/12/2011 | US7977064 Disheveled PDZ modulators |
| 07/12/2011 | US7977059 17867, a novel human aminopeptidase |
| 07/12/2011 | US7977047 Delete sequence in M. tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 07/12/2011 | US7976879 Nutritional supplement product to suppress age-related decline in cognitive capacity and other aging functions |
| 07/12/2011 | US7976863 Bonding synthetic antimicrobial cationic peptide to medical device using coupling agent; polymerizing (meth)acryloyl polpeptide comprising melimine and/or protattin; catheters, contact lenses, stents, bags, tubes, bandages; ophthalmology |
| 07/12/2011 | US7976860 A porous protein matrix with a structural component partly or fully anchored in the matrix; at least one surface has a protein membrane crosslinked with the matrix; sufficient stability with improved flexibility, biocompatibility and absorption; vascular prosthetics |
| 07/12/2011 | US7976849 Hepatitis-C virus testing |
| 07/12/2011 | US7976847 Congestive heart failure; antiischemic agents; administering calcitonin gene related peptide in thermoplastic biocompatible polymer; controlled release or maintenance therapy |
| 07/12/2011 | US7976846 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor |
| 07/12/2011 | US7976840 Use of anti-GL50 antibodies for the downmodulation of an immune response |
| 07/12/2011 | US7976837 Method of preventing and treating brain infarction |
| 07/12/2011 | US7976835 Methods and compositions for preventing and treating solid tumors |
| 07/12/2011 | US7976833 Ophthalmic surgical irrigating solutions containing hyaluronidase and method for preventing post-operative intraocular pressure increases |
| 07/12/2011 | US7976826 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 07/12/2011 | CA2526957C Long lasting insulin derivatives and methods thereof |